Emal Lesha

Emal Lesha

Auto-generated profile, based on publicly available information

Emal Lesha

Department of Neurosurgery, University of Tennessee Health Science Center, Memphis, Tennessee, USA

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 September 2017 in Science
Verified
Journal Article
Closed access
PDF file
DNDong Niu
Dong Niu
HWHong-jiang Wei
Hong-jiang Wei
LLLin Lin
Lin Lin
HGHaydy George
Haydy George
TWTao Wang
Tao Wang
LYLuhan Yang
Luhan Yang
Taking the PERVs out of pigs: With the severe shortage of organs needed for transplants, xenotransplantation (transplantation of nonhuman organs to humans) offers an alternative source. Some pig organs have similar size and function to those of humans. The challenge is that the pig genome harbors porcine endogenous retroviruses (PERVs) that can potentially pass to humans with possibly damaging consequences. Niu et al. generated pigs in which all copies of PERVs were inactivated by CRISPR-Cas9 genome engineering (see the Perspective by Denner). Not only does this work provide insights into PERV activity, but it also opens the door to a safer source of organs and tissues for pig-to-human xenotransplantation. Science , this issue p. 1303 ; see also p. 1238

27 November 2015 in Science
Verified
Journal Article
Closed access
PDF file
LYLuhan Yang
Luhan Yang
MGMarc Güell
Marc Güell
DNDong Niu
Dong Niu
HGHaydy George
Haydy George
ELEmal Lesha
Emal Lesha
GCGeorge Church
George Church
Virally cleansing the pig genome: Transplants from pigs could be a solution to a shortage of human organs for transplantation. Unfortunately, porcine endogenous retroviruses (PERVs) are rife in pigs and can be transmitted to humans, risking disease. L. Yang et al. integrated CRISPR-Cas into the pig cell genome, where continuous induction of the Cas9 editing enzyme resulted in the mutation of every single PERV reverse transcriptase gene. This prevented replication of all copies of PERV, viral infection, and transmission to human cells. Science , this issue p. 1101

22 January 2016 in Advanced Healthcare Materials
Verified
Journal Article
Closed access
PDF file
ATAli Tamayol
Ali Tamayol
Mohsen AkbariMohsen Akbari
Mohsen Akbari
YZYael Zilberman
Yael Zilberman
MCMattia Comotto
Mattia Comotto
ELEmal Lesha
Emal Lesha
Ali  KhademhosseiniAli Khademhosseini
Ali Khademhosseini

2 November 2016 in Nature Communications
Verified
Journal Article
Open access
LYLuhan Yang
Luhan Yang
ABAdrian W. Briggs
Adrian W. Briggs
WCWei Leong Chew
Wei Leong Chew
PMPrashant Mali
Prashant Mali
MGMarc Guell
Marc Guell
GCGeorge Church
George Church
Precise editing is essential for biomedical research and gene therapy. Yet, homology-directed genome modification is limited by the requirements for genomic lesions, homology donors and the endogenous DNA repair machinery. Here we engineered programmable cytidine deaminases and test if we could introduce site-specific cytidine to thymidine transitions in the absence of targeted genomic lesions. Our programmable deaminases effectively convert specific cytidines to thymidines with 13% efficiency in Escherichia coli and 2.5% in human cells. However, off-target deaminations were detected more than 150 bp away from the target site. Moreover, whole genome sequencing revealed that edited bacterial cells did not harbour chromosomal abnormalities but demonstrated elevated global cytidine deamination at deaminase intrinsic binding sites. Therefore programmable deaminases represent a promising genome editing tool in prokaryotes and eukaryotes. Future engineering is required to overcome the processivity and the intrinsic DNA binding affinity of deaminases for safer therapeutic applications.

13 August 2021 in Science Advances
Verified
Journal Article
Open access
MZMark M. Zaki
Mark M. Zaki
ELEmal Lesha
Emal Lesha
KSKhaled Said
Khaled Said
KKKiavash Kiaee
Kiavash Kiaee
LRLindsey Robinson-McCarthy
Lindsey Robinson-McCarthy
GCGeorge Church
George Church
Cell therapy has strong promise for treating COVID-19 survivors due to customizability, targetability, and regenerative function.

1 November 2015 in Endocrine Practice
Verified
Journal Article
Closed access
MGMohammad Ghasemi-Rad
Mohammad Ghasemi-Rad
ELEmal Lesha
Emal Lesha
SASaeed Abkhiz
Saeed Abkhiz
AMAfshin Mohammadi
Afshin Mohammadi